Paper2901430
Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy.
Samaan NA and 2 others. J Clin Endocrinol Metab, 1988. Cited by 121 papers, by iCite.
Cite this record
ConductScience Library. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. Papers, record 2901430. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2901430
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Multiple Endocrine Neoplasia | Major topic |
| Thyroid Neoplasms | Major topic |
| Adult | |
| Age Factors | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-27612-06 | NCI NIH HHS | United States | PubMed | PubMed | |
| R01CA027612 | NIH | NIH RePORTER |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38441533 | Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. | J Clin Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38441533 | PubMed |
| 35116326 | Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116326 | PubMed |
| 34372848 | Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer. | BMC Endocr Disord | 2021 | https://conductscience.org/library/papers/34372848 | PubMed |
| 32452872 | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis. | Am J Surg Pathol | 2020 | https://conductscience.org/library/papers/32452872 | PubMed |
| 31778360 | The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma. | Endocr Connect | 2020 | https://conductscience.org/library/papers/31778360 | PubMed |
| 30618340 | Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study. | Thyroid | 2019 | https://conductscience.org/library/papers/30618340 | PubMed |
| 26783427 | Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature. | Clin Case Rep | 2016 | https://conductscience.org/library/papers/26783427 | PubMed |
| 24942936 | Medical management of metastatic medullary thyroid cancer. | Cancer | 2014 | https://conductscience.org/library/papers/24942936 | PubMed |
| 24179649 | A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience. | Rare Tumors | 2013 | https://conductscience.org/library/papers/24179649 | PubMed |
| 23011723 | Medullary thyroid cancer--current treatment strategy, novel therapies and perspectives for the future. | Horm Cancer | 2012 | https://conductscience.org/library/papers/23011723 | PubMed |
| 22371144 | Occult primary medullary thyroid carcinoma presenting with pituitary and parotid metastases: case report and review of the literature. | Endocr Pathol | 2012 | https://conductscience.org/library/papers/22371144 | PubMed |
| 20648590 | Adjuvant external beam radiation for medullary thyroid carcinoma. | J Surg Oncol | 2010 | https://conductscience.org/library/papers/20648590 | PubMed |
| 16369705 | Prognostic factors for sporadic medullary thyroid carcinoma. | World J Surg | 2006 | https://conductscience.org/library/papers/16369705 | PubMed |
| 15233908 | Multiple endocrine neoplasia type 2. | Curr Treat Options Oncol | 2004 | https://conductscience.org/library/papers/15233908 | PubMed |
| 12771918 | Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12771918 | PubMed |
| 12172572 | Markov model-based estimation of individual survival probability for medullary thyroid cancer patients. | Pathol Oncol Res | 2002 | https://conductscience.org/library/papers/12172572 | PubMed |
| 12057161 | Medullary thyroid cancer. | Curr Treat Options Oncol | 2000 | https://conductscience.org/library/papers/12057161 | PubMed |
| 10561095 | Surgical strategy for the treatment of medullary thyroid carcinoma. | Ann Surg | 1999 | https://conductscience.org/library/papers/10561095 | PubMed |
| 9617595 | Drug therapy alternatives in the treatment of thyroid cancer. | Drugs | 1998 | https://conductscience.org/library/papers/9617595 | PubMed |
| 9065657 | Surgical treatment strategy for thyroid gland carcinoma nodal metastases. | Eur Arch Otorhinolaryngol | 1997 | https://conductscience.org/library/papers/9065657 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2901430
GET https://conductscience.org/api/papers/v1/2901430/cited_by?page=2